Skip to main content

Data suggest community involvement is the key to controlling infectious disease

The battles against infectious diseases are challenging enough in Western countries with stable infrastructure and deep-pocketed pharmaceutical firms. In an impoverished section of Latin America, they are much more difficult. But new research from Rockefeller University’s Joel E. Cohen suggests t...

Recently discovered cell is unexpected player in psoriasis

When the FDA assesses a drug, it looks closely at its safety and its effectiveness, but it doesn’t require a precise understanding of how the drug works. A new study by Rockefeller University scientists shows that a strikingly successful psoriasis drug, etanercept, may not act on the immune cells...

Stress response in the brain relies on a blood-thinning protein

A stressed-out mouse tends to be a bit timid, tentative, even fearful. For that matter, so does a stressed-out human. Our ability to learn from frightening situations is part of what helps us avoid them in the future. When that learning process goes awry, it can lead to depression and a decreased...

A protein converts immune cells to tumor killers

Tumor cells are masters at evading detection. But new research from Rockefeller University shows how they can be exposed. By harnessing the immune system of patients with a rare neurological disorder, scientists have figured out how to transform immune cells that barely detect the presence of bre...

Biologists use microfluidics chips to watch worm behavior

Tiny roundworms called Caenorhabditis elegans have a rather uncomplicated method for finding food: They wriggle and turn and explore new territory until they find something edible, and then they stay the course until the food disappears. But despite the worm’s simple nervous system, researchers ...

Pilot study to probe link between kidney disease and heart disease

Kidney disease isn’t just about kidneys: Research has shown that people with kidney abnormalities have a dramatically increased risk of heart disease. But by studying blood samples from patients with early-stage kidney disease, researchers at The Rockefeller University Hospital hope to better def...

Announcements

Visiting Scholars Program seminars begin next week. During their stay, Rockefeller’s visiting scholars, Peter Goodfellow and Philip Campbell, will give special seminars, together and separately. The schedule, along with their campus contact information, is below. Peter Goodfellow: Monday, October...

Pharma exec, editor to be university's first visiting scholars

by TALLEY HENNING BROWN For a few weeks this fall, talk on campus will step beyond basic science. Former pharmaceutical executive Peter Goodfellow and Nature editor in chief Philip Campbell will join The Rockefeller University this month as its first visiting scholars. The Visiting Scholars Progr...

Why visiting scholars?

One of the strategic aims identified in the plan for the university is to foster interactions among scientists at all levels. Over the past few years we have introduced a number of vehicles to encourage greater intellectual exchange. These include the Monday Lecture Series, now entering its third...

Princeton physicist joins Rockefeller as part-time visiting professor

by TALLEY HENNING BROWN There’s more than one way to visit. While Peter Goodfellow and Philip Campbell will each spend a few weeks here as visiting scholars, William Bialek has committed to a longer-term stay as a part-time visiting professor. A theoretical physicist and professor at Princeton U...